The Efficacy and Safety of Rifaximin Treatment

Clinical trial NCT05786859 · UNKNOWN

Trial details

NCT number: NCT05786859
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Early Phase 1
Study type: INTERVENTIONAL

Liver Failure, Acute on Chronic Hepatic Encephalopathy HBV Hepatitis B Rifaximin Effect of Drug

Start date: 2023-03-09
Primary completion: 2025-07-31
Enrollment: 124

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.